Xiumin Wang | Infectious Diseases Prevention, Control and Cure | Innovative Research Award

Posted on by Infectious

Innovative Research Award

Xiumin Wang
Institute of Feed Research, Chinese Academy of Agricultural Sciences

Xiumin Wang
Affiliation Institute of Feed Research, Chinese Academy of Agricultural Sciences
Country China
Scopus ID 36971321100
Documents 113
Citations 2,788
h-index 30
Subject Area Infectious Diseases Prevention, Control and Cure
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-2008-856X

The Innovative Research Award recognizes distinguished scientific achievements that contribute to the advancement of infectious disease prevention, control, and therapeutic development. Xiumin Wang has established a notable academic profile through sustained research activities, publication output, and interdisciplinary investigations within animal health, microbial sciences, feed safety, and infectious disease management. The researcher’s scholarly contributions have supported scientific understanding of pathogen interactions, host responses, and evidence-based disease mitigation strategies within agricultural and public health contexts.[1]

Abstract

Xiumin Wang has developed an extensive body of research addressing infectious disease prevention, microbial ecology, animal nutrition, feed safety, and host–pathogen interactions. Through interdisciplinary investigations, the researcher has contributed to understanding mechanisms that influence disease transmission, immune responses, and biological control strategies in agricultural systems. Scholarly publications demonstrate consistent engagement with topics relevant to microbial management and health optimization. Supported by a substantial publication record, citation performance, and international visibility, Wang’s research has enhanced scientific knowledge while contributing practical insights for disease mitigation, sustainable production systems, and evidence-based approaches supporting infectious disease control and prevention initiatives worldwide.[1][2]

Keywords

Infectious Diseases, Disease Prevention, Feed Safety, Microbial Ecology, Host–Pathogen Interaction, Animal Health, Immunology, Antimicrobial Research, Agricultural Biosciences, Disease Control.

Introduction

The prevention and control of infectious diseases require collaborative research efforts spanning microbiology, immunology, epidemiology, and agricultural sciences. Scientific advances in these areas support improved understanding of disease dynamics and facilitate the development of innovative intervention strategies. Xiumin Wang’s research portfolio reflects this interdisciplinary perspective, integrating biological and applied sciences to address challenges associated with pathogen management, animal productivity, and public health protection.[2]

Research Profile

Affiliated with the Institute of Feed Research at the Chinese Academy of Agricultural Sciences, Xiumin Wang has established a research profile characterized by significant scholarly productivity and sustained scientific influence. The researcher’s Scopus-indexed publication record includes more than one hundred documents and a citation count approaching three thousand, demonstrating broad engagement with topics relevant to infectious diseases, microbial regulation, nutrition-associated immunity, and disease prevention technologies. The achieved h-index further reflects the consistency and impact of these scientific contributions.[1]

Research Contributions

Wang’s research contributions have focused on advancing knowledge regarding microbial communities, feed-associated biological interventions, pathogen control mechanisms, and host immune regulation. These investigations have generated evidence supporting improved health management practices while expanding scientific understanding of interactions between nutrition, microbiota, and disease susceptibility. The resulting findings have contributed to ongoing efforts aimed at reducing disease risks and promoting sustainable approaches to infectious disease prevention within animal production systems.[3][4]

Publications

The publication portfolio of Xiumin Wang encompasses peer-reviewed journal articles addressing microbial biotechnology, feed-derived bioactive compounds, pathogen resistance, animal health, and infectious disease management. Research outputs have appeared in internationally recognized scientific journals and have attracted considerable scholarly attention. Several studies have explored biological alternatives to conventional disease-control measures, reflecting contemporary priorities in antimicrobial stewardship and sustainable health interventions.[3]

Research Impact

The measurable impact of Wang’s scholarship is reflected through citation performance, research visibility, and continued relevance within scientific literature. Contributions have informed subsequent investigations examining microbial regulation, disease prevention, and health optimization strategies. By connecting fundamental biological research with practical applications, the work has supported knowledge transfer across academic, veterinary, agricultural, and public health disciplines, thereby strengthening broader efforts toward effective infectious disease control.[1][4]

Award Suitability

Xiumin Wang demonstrates strong alignment with the objectives of the International Research Awards on Infectious Diseases. The researcher’s established publication record, substantial citation impact, interdisciplinary expertise, and contributions to disease prevention science collectively support consideration for recognition under the Innovative Research Award category. The combination of scientific productivity and practical relevance illustrates a sustained commitment to advancing research that contributes to improved disease management and health outcomes.[1][5]

Conclusion

The academic achievements of Xiumin Wang reflect a sustained and impactful contribution to infectious disease-related research. Through extensive publication activity, influential scientific findings, and interdisciplinary collaboration, the researcher has strengthened understanding of disease prevention and biological health management. These accomplishments support recognition within international research award frameworks dedicated to innovation, scientific excellence, and meaningful advancement of infectious disease research.

References

  1. Elsevier. (n.d.). Scopus author details: Xiumin Wang, Author ID 36971321100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36971321100
  2. ORCID. (n.d.). Xiumin Wang Research Profile.
    https://orcid.org/0000-0002-2008-856X
  3. Microorganisms. (2025). Anti-Inflammatory and Antidiarrheal Effects of Two Strains of Lactic Acid Bacteria Isolated from Healthy Pets on Escherichia coli K88-Induced Diarrhea in Mice.
    https://doi.org/10.3390/microorganisms13020239
  4. Zhenlong Wang, ,Xiumin Wang, Jianhua Wang. (2018). Recent Advances in Antibacterial and Antiendotoxic Peptides or Proteins from Marine Resources.
    https://doi.org/10.3390/md16020057
  5. International Research Awards on Infectious Diseases. (2026). Award Information and Recognition Framework.
    https://infectious-diseases-conferences.pencis.com/

Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Posted on by Infectious

Dr. Achilleas Livieratos | Infectious Diseases Vaccines | Best Researcher Award

Medical Researcher | Stanford University | Greece

Dr. Achilleas Livieratos, PhD, MRSB, is a distinguished biomedical researcher whose work bridges immunology, infectious diseases, circadian biology, and artificial intelligence applications in health sciences. His research integrates advanced computational methods, including machine learning and multi-agent transformer frameworks, to enhance evidence generation, vaccine immunology, and drug safety analytics. He has published extensively in leading journals such as Vaccines, Pathogens, Viruses, eClinicalMedicine, and Value in Health, contributing to global understanding of immune response dynamics, precision medicine, and outcomes research. Notably, his development of MetaMind, an AI-driven framework for automated network meta-analyses, and his studies on circadian influences on influenza vaccine immunity have been recognized as groundbreaking contributions. His investigations into immune durability across respiratory viruses, including RSV, SARS-CoV-2, and influenza, as well as his exploration of alternative therapies for long COVID, have significantly advanced clinical and translational knowledge. As a lead collaborator with Stanford University and the University of California, San Francisco, Dr. Livieratos has directed international research initiatives on infectious disease modeling, biomarker discovery, and the application of AI in health outcomes research. His earlier work at the University of Oxford produced landmark discoveries in neurogenetics and circadian disruption, underpinning his multidisciplinary expertise. Through leadership in European Pharma and AI consortia, he continues to drive innovation in predictive health analytics and precision therapeutics, demonstrating an exceptional fusion of biomedical insight, computational innovation, and translational research impact.

Profiles : Google Scholar | Scopus

Featured Publication

Oliver, P. L., Sobczyk, M. V., Maywood, E. S., Edwards, B., Lee, S., Livieratos, A., et al. (2012). Disrupted circadian rhythms in a mouse model of schizophrenia. Current Biology, 22(4), 314–319.

Taylor, T. N., Potgieter, D., Anwar, S., Senior, S. L., Janezic, S., Threlfell, S., Ryan, B., et al. (2014). Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiology of Disease, 62, 193–207.

Wobst, H. J., Denk, F., Oliver, P. L., Livieratos, A., Taylor, T. N., Knudsen, M. H., et al. (2017). Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Scientific Reports, 7(1), 43198.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Impact of prior COVID-19 immunization and/or prior infection on immune responses and clinical outcomes. Viruses, 16(5), 685.

Livieratos, A., Gogos, C., & Akinosoglou, K. (2024). Beyond antivirals: Alternative therapies for long COVID. Viruses, 16(11), 1795.

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Posted on by Infectious

Prof. huakun lv | Infectious Diseases Vaccines | Best Researcher Award

Zhejiang Provincial Center for Disease Control and Prevention | China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Huakun Lv earned his Master of Science in Epidemiology and Health Statistics from the School of Public Health, Southeast University, Nanjing, in 2005. Prior to that, he completed his Bachelor of Science in Preventive Medicine at the same institution in 1992. His academic journey laid a strong foundation in public health, epidemiology, and disease prevention, equipping him with the expertise to address complex health challenges and lead immunization initiatives.

💼PROFESSIONAL ENDEAVORS

Dr. Lv, Chief Physician and Director of the Immunization Program at Zhejiang CDC, has been a driving force in vaccine strategies, coverage, and disease prevention since 2014. Previously, as Deputy Director of Infectious Disease Control and Prevention (2005–2014), he played a pivotal role in infectious disease surveillance, building on his frontline public health experience at Danyang CDC, Jiangsu Province (1992–2002). Beyond his institutional leadership, he has made significant global health contributions, serving as an Epidemiologist in the Chinese Government Emergency Medical Team in the Philippines (2013) during the Typhoon Haiyan response and as Deputy Director of the Zhejiang Public Health and Medical Team in Qingchuan, Sichuan Province (2008) after the Sichuan Earthquake. His expertise in applied epidemiology was further strengthened as a Visiting Scholar at Emory University’s School of Public Health (2011).

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASE VACCINES

Dr. Lv’s research primarily focuses on epidemiology and the prevention of vaccine-preventable diseases. His work encompasses immunization program policies, the effectiveness of vaccination strategies, and the epidemiology and virology of Hand, Foot, and Mouth Disease (HFMD). He has also conducted significant studies on biofilm resistance and endoscopic disinfection practices, contributing to the broader understanding of infection control. His involvement in vaccine clinical trials and public health interventions has played a crucial role in shaping vaccine policies and improving disease prevention measures.

🌍IMPACT AND INFLUENCE

Dr. Lv’s impact on public health extends beyond Zhejiang Province, as he has been at the forefront of immunization initiatives that have improved vaccine accessibility and effectiveness. His expertise in epidemiology has led to substantial contributions in global disease control efforts. His involvement in emergency medical responses and his advisory roles in infectious disease management have positioned him as a key figure in international public health collaborations.

📚ACADEMIC CITATIONS

Dr. Lv’s research has been widely recognized and cited in scientific publications. Notable among his achievements is his study on the Epidemiological and Etiological Characteristics of HFMD in Zhejiang Province, which earned him a Second Prize Award. Additionally, his research on the Effect of Endoscopic Cleaning and Disinfection on Biofilm received a Third Prize Award. His publications have contributed significantly to the understanding of infectious disease epidemiology and vaccine effectiveness, influencing public health policies and practices.

🏆RESEARCH GRANTS AND FUNDING

Dr. Lv has successfully secured multiple research grants for immunization and epidemiology projects. His funding contributions have supported vaccine clinical trials, public health surveillance initiatives, and innovative disease prevention strategies. These grants have facilitated critical research aimed at enhancing vaccination programs and improving disease control efforts at both national and international levels.

🦠LEGACY AND FUTURE CONTRIBUTIONS

With a commitment to mentoring the next generation of epidemiologists and public health professionals, Dr. Lv continues to play an active role in academia and research. His dedication to advancing vaccine research, implementing effective immunization policies, and fostering global collaborations in infectious disease prevention underscores his lasting impact on public health. His vision is to continue developing innovative strategies that address emerging infectious diseases and strengthen global health security.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lv holds several prestigious positions in professional organizations. He serves as Vice-Chairman of the Division of Immunology at the Zhejiang Preventive Association and is a Master Supervisor at the School of Public Health, Xiamen University. He is also a Field Tutor for the Chinese Field Epidemiology Training Program (CFETP) at the Chinese CDC and a Research Supervisor at the Chinese Hepatitis Prevention and Treatment Foundation. Additionally, he is a Standing Committee Member of the Division of Vaccine Clinical Trials at the China Association for Vaccines (CAV). His leadership in these roles reflects his commitment to advancing infectious disease research, vaccine development, and public health policy.

📑NOTABLE PUBLICATIONS

A phase 3 clinical trial on the immunogenicity and safety of booster vaccination after Zagreb or Essen regimens

Authors: H. Lv, Huakun; X. Chen, Xu; B. Xing, Bo; Z. Liang, Zhenzhen; Y. Mao, Yu
Year: 2025
Journal: Scientific Reports

Immunogenicity and safety of live attenuated influenza vaccine in children aged 3–17 years in China

Authors: L. Ai, Lizhe; Z. Gao, Zhao; H. Lv, Huakun; D. Liu, Dawei; Q. Yu, Qiong
Year: 2025
Journal: Vaccine

Validation of a questionnaire for evaluating vaccine literacy in adulthood vaccination: A pilot study from Zhejiang province, China

Authors: X. Luo, Xiaofu; J. Shen, Jianyong; H. Lv, Huakun; Y. Hu, Yu
Year: 2025
Journal: Human Vaccines and Immunotherapeutics

Safety, immunogenicity and immune-persistence of a lyophilized human rabies vaccine (Vero cells) under Zagreb and Essen regimens: a randomized, open-label, controlled phase III clinical trial in healthy participants aged 10–60 years in China

Authors: Z. Liang, Zhenzhen; X. Chen, Xu; B. Xing, Bo; H. Lv, Huakun; Y. Mao, Yu
Year: 2024
Journal: Frontiers in Immunology

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China

Authors: H. Zhang, Hangjie; Q. Hua, Qianhui; J. Jiang, Jianmin; H. Lv, Huakun
Year: 2023
Journal: eLife

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Katerina Trejbalova | Animal Infectious Diseases | Best Researcher Award

Institute of Molecular Genetics of the Czech Academy of Sciences | Czech Republic.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Katerina Trejbalova began her academic journey with a deep interest in veterinary microbiology and infectious diseases. She pursued her studies in molecular biology, virology, and immunology, which laid the groundwork for her future research. Her doctoral research focused on host-pathogen interactions, particularly in animal infectious diseases, equipping her with extensive expertise in disease prevention and control strategies.

💼PROFESSIONAL ENDEAVORS

Dr. Trejbalova has held influential roles in academic institutions, veterinary research centers, and global health organizations. She has worked extensively in disease surveillance, vaccine development, and epidemiological studies. As a researcher, educator, and mentor, she has significantly contributed to shaping the next generation of scientists in veterinary infectious diseases and public health.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON ANIMAL INFECTIOUS DISEASES

Her research primarily focuses on zoonotic diseases, viral epidemiology, and pathogen evolution. Dr. Trejbalova has made significant contributions to the early detection of viral outbreaks, vaccine efficacy studies, and molecular diagnostics. She has worked on novel therapeutic interventions for highly contagious livestock diseases, aiding in pandemic preparedness and disease eradication programs.

🌍IMPACT AND INFLUENCE

Dr. Trejbalova’s work has had a profound global impact on animal health policies, veterinary public health, and biosecurity initiatives. She has collaborated with international research institutions and governmental bodies to develop strategies for controlling infectious diseases in livestock and wildlife. Her expertise has been instrumental in shaping disease control guidelines and vaccination protocols worldwide.

📚ACADEMIC CITATIONS

Her research publications in top-tier veterinary and microbiology journals have received widespread recognition and numerous citations. Dr. Trejbalova’s studies are frequently referenced in epidemiological research, virology, and disease management, solidifying her reputation as a leading authority in infectious disease research.

🏆RESEARCH GRANTS AND FUNDING

Dr. Trejbalova has successfully secured competitive research grants from prestigious funding agencies to support her work in viral pathogenesis, disease modeling, and advanced diagnostic techniques. Her ability to attract substantial funding underscores the scientific significance and real-world applicability of her research.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Trejbalova’s legacy is defined by her groundbreaking contributions to veterinary medicine and infectious disease control. She continues to explore genetic factors influencing disease susceptibility, next-generation vaccine formulations, and AI-driven disease tracking systems. Her future research aims to enhance global disease preparedness and improve the resilience of veterinary healthcare systems.

🌟A VISIONARY IN INFECTIOUS DISEASES

As a pioneer in veterinary microbiology, Dr. Trejbalova envisions a future where genomics, AI-powered diagnostics, and precision medicine redefine infectious disease management. Her unwavering dedication to scientific innovation and global health security establishes her as a trailblazer in the field.

📑NOTABLE PUBLICATIONS

 Receptor usage of Syncytin-1: ASCT2, but not ASCT1, is a functional receptor and effector of cell fusion in the human placenta

Authors: K. Štafl, Kryštof; M. Trávníček, Martin; A. Janovska, Anna; J. Hejnar, Jiří; K. Trejbalová, Kateřina
Publication Year: 2024
Journal: Proceedings of the National Academy of Sciences of the United States of America (PNAS)

 Antibiotic-Loaded Amphiphilic Chitosan Nanoparticles Target Macrophages and Kill an Intracellular Pathogen

Authors: J. Trousil, Jiří; N.J.K. Dal, Nils Jørgen Knudsen; F. Fenaroli, Federico; O. Pavliš, Ota; A.D. Sosnik, Alejandro D.
Publication Year: 2022
Citations: 13

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Posted on by Infectious

Prof. Zhongde Zhang | Infectious Diseases Prevention | Best Researcher Award

Guangzhou University of Chinese Medicine| China.

Author Profile

Scopus

🎓EARLY ACADEMIC PURSUITS

Professor Zhongde Zhang embarked on his academic journey with a profound focus on Traditional Chinese Medicine (TCM). His foundational studies at prestigious institutions in China enabled him to master both the theoretical and practical aspects of TCM, paving the way for his expertise in addressing complex health challenges, particularly in infectious disease prevention.

💼PROFESSIONAL ENDEAVORS

As the President of Guangdong Provincial Hospital of Traditional Chinese Medicine and Vice-President of Guangzhou University of Traditional Chinese Medicine, Professor Zhang has played a pivotal role in advancing TCM’s integration into modern medical systems. His leadership has elevated both institutions into centers of excellence, emphasizing research, education, and patient-centered care.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES PREVENTION

Professor Zhang’s contributions to infectious diseases prevention are revolutionary. His research emphasizes the synergistic potential of TCM and modern medicine in addressing respiratory diseases and other intractable illnesses. His groundbreaking approaches include developing TCM-based immune therapies, advancing the understanding of pathogenesis, and creating integrative treatment protocols.

🌍IMPACT AND INFLUENCE

Professor Zhang’s influence transcends national boundaries. His advocacy for the integration of Traditional and Modern Medicine in global health policies has positioned him as a global health advocate. His efforts in addressing antibiotic resistance, pandemics, and chronic respiratory diseases have significantly improved public health outcomes and reinforced TCM’s role in international health systems.

📚ACADEMIC CITES

With a prolific record of peer-reviewed publications, Professor Zhang’s research is widely recognized and frequently cited in international journals. His work has provided a robust evidence base for TCM applications in infectious disease prevention and treatment, further bridging the gap between Eastern and Western medicine.

🏆RESEARCH GRANTS AND FUNDING

Professor Zhang has successfully led projects under the Ministry of Science and Technology’s major research and development program and secured multiple National Natural Science Foundation grants. These prestigious grants have fueled innovative studies on infectious diseases, respiratory illnesses, and immune system modulation, strengthening his position as a leading researcher in TCM.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Professor Zhang’s legacy lies in his vision for the future of healthcare, where TCM seamlessly integrates with modern medical advancements. His commitment to mentorship, innovative research, and developing global collaborations ensures a lasting impact on medical science and infectious disease prevention.

🌟A VISIONARY IN INFECTIOUS DISEASES

Recognized as a National Famous TCM Scholar, Professor Zhang embodies the spirit of innovation and collaboration. His visionary leadership has redefined the role of TCM in preventing and managing infectious diseases, marking him as a trailblazer in this field.

📑NOTABLE PUBLICATIONS 

“Fuzheng Jiedu decoction alleviates H1N1 virus-induced acute lung injury in mice by suppressing the NLRP3 inflammasome activation”

Authors: Li, Y., Zou, H., Ma, L., …, Li, G., Zhang, Z.
Publication Year: 2025
Journal: Journal of Ethnopharmacology

” Inhalable and bioactive lipid-nanomedicine based on bergapten for targeted acute lung injury therapy via orchestrating macrophage polarization”

Authors: Liao, R., Sun, Z.-C., Wang, L., …, Wu, J., Zhang, Z.
Publication Year: 2025
Journal: Bioactive Materials

“Efficacy and safety of integrated traditional Chinese and Western medicine for rheumatoid arthritis-interstitial lung disease: A systematic review and meta-analysis”

Authors: Lu, P., Li, L., Liu, B., …, Zhang, Z., Lu, C.
Publication Year: 2024
Journal: Heliyon

“Natural pachypodol integrated, lung targeted and inhaled lipid nanomedicine ameliorates acute lung injury via anti-inflammation and repairing lung barrier”

Authors: Sun, Z.-C., Liao, R., Xian, C., …, Liu, Y., Wu, J.
Publication Year: 2024
Journal: Journal of Controlled Release

“Mendelian randomization and Bayesian model averaging of autoimmune diseases and Long COVID”

Authors: Feng, J., Chen, J., Li, X., …, Lu, Y., Liu, Y.
Publication Year: 2024
Journal: Frontiers in Genetics

Dr. Yuliang Liu | Animal Infectious Diseases | Best Researcher Award

Posted on by Infectious

Dr. Yuliang Liu | Animal Infectious Diseases | Best Researcher Award

China Animal Disease Control Center | China.

Author Profile

Scopus

🎓Education

Dr. Yuliang Liu, born on October 22, 1973, in Inner Mongolia, China, is a renowned professor at the China Animal Disease Control Center (CADC) since 2012. He holds a Ph.D. in Veterinary Science from Yangzhou University (2005), an M.Sc. in Veterinary Science from Guangxi University (2001), and a B.Sc. in Veterinary Medicine from Inner Mongolia Agricultural University (1998). His global experience includes postdoctoral research at the University of Pennsylvania (USA) and the Technical University of Denmark (DTU).

💼Professional Experience

Dr. Liu has over two decades of expertise in animal and zoonotic disease control, diagnostics, biosafety measures, and vaccine development. His work spans international collaborations and significant contributions to drafting Chinese standards for diagnosing animal diseases. He has supervised 17 students, including undergraduates and Ph.D. candidates, fostering future leaders in veterinary science.

🔬Technical Skills

Dr. Liu is skilled in molecular biology techniques, including reverse genetics, nucleic acid detection, and antimicrobial resistance research. His expertise in preparing Certified Reference Materials (CRMs) has led to the commercialization of five CRMs, enhancing diagnostic tools in veterinary medicine.

🔬Research Interests

A proponent of the One-Health approach, Dr. Liu focuses on animal disease surveillance, control, and vaccine innovation, emphasizing the intersection of animal and human health. His research extends to AMR studies and biosafety technologies.

📚Academic Contributions 

Dr. Liu is an editor for the journal Viruses and a member of professional societies like the American Society for Virology and the Chinese Veterinary Association. As a peer reviewer, he contributes to esteemed journals, including Viruses, Gene, and JAC-Antimicrobial Resistance.

🏆Awards & Recognition

  • Shen Nong China Agricultural Science and Technology Award (2017, 1st Prize)
  • Innovation Prize of DA BEI NONG Science and Technology Award (2015)
  • Named Outstanding Employee of CADC (2020–2022)

🎙️Teaching & Conferences

Dr. Liu has presented research globally, including at the World Organization for Animal Health (OIE) and the American Society for Virology. His mentorship has shaped the careers of many in the veterinary field.

Through his work, Dr. Liu continues to bridge scientific innovation and practical solutions for animal health worldwide.

📑Notable Publications 

“Development of Broad-Spectrum Nanobodies for the Therapy and Diagnosis of SARS-CoV-2 and Its Multiple Variants”

Authors: He, L.; Wu, Q.; Zhang, Z.; Fan, R.; Li, Y.-P.
Year: 2024
Journal: Molecular Pharmaceutics, 21(8), pp. 3866–3879

“The proteomic analysis uncovers the cellular responses to the African swine fever virus membrane proteins p54, p17, and pB117L”

Authors: Chen, Y.; Ni, J.; Wang, C.; Wei, Y.; Liu, Y.
Year: 2024
Journal: Microbes and Infection, 26(5-6), Article 105348

“Establishment of a Triplex qPCR Assay for Differentiating Highly Virulent Genotype I Recombinant Virus from Low-Virulence Genotype I and Genotype II African Swine Fever Viruses Circulating in China”

Authors: Ding, L.; Ren, T.; Bing, G.; Sun, E.; Zhao, D.
Year: 2024
Journal: Transboundary and Emerging Diseases, Article ID 6206857

“Sequence characteristics and phylogenetic analysis of H9N2 subtype avian influenza A viruses detected from poultry and the environment in China, 2018”

Authors: Gao, X.; Wang, N.; Chen, Y.; Wang, C.; Liu, Y.
Year: 2021
Journal: PeerJ, 9, Article e12512

“An oligonucleotide-tagged microarray for routine diagnostics of colon cancer by genotyping KRAS mutations”

Authors: Liu, Y.; Gudnason, H.; Li, Y.-P.; Bang, D.D.; Wolf, A.
Year: 2014
Journal: International Journal of Oncology, 45(4), pp. 1556–1564

Introduction of Animal Infectious Diseases

Posted on by Infectious

Introduction of Animal infectious diseases

Animal infectious diseases are illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites that can affect a wide range of animal species. These diseases can spread through direct contact between animals, contaminated water or food, vectors like insects, or environmental exposure.

Types of Animal Infectious Diseases

Viral Diseases:

Foot-and-Mouth Disease (FMD): Affects cloven-hoofed animals like cattle, sheep, and pigs. It's highly contagious and causes fever, blisters in the mouth and on feet, and can lead to severe economic losses.

Rabies: A fatal viral disease that affects the nervous system of mammals, including humans. It's transmitted through the saliva of infected animals, usually via bites.

Bacterial Diseases:

Anthrax: Caused by Bacillus anthracis, it affects cattle, sheep, and other herbivores, and can be transmitted to humans. It causes severe symptoms like sudden death in animals.

Brucellosis: Affects cattle, goats, and pigs, leading to reproductive issues like abortions. It can also be transmitted to humans, causing flu-like symptoms.

Parasitic Diseases:

Toxoplasmosis: Caused by the parasite Toxoplasma gondii, it can affect most warm-blooded animals, including humans. It often leads to neurological issues and reproductive problems.

Trypanosomiasis (Sleeping Sickness): Caused by Trypanosoma parasites, it's transmitted by tsetse flies and affects both animals and humans, leading to severe neurological issues.

Fungal Diseases:

Ringworm: A skin infection caused by various fungi, it affects many animals, including cattle, dogs, and cats. It causes circular patches of hair loss and skin irritation.

Transmission and Impact

Direct Transmission: Through physical contact, bites, or close proximity.

Indirect Transmission: Via contaminated feed, water, equipment, or bedding.

Vector-Borne Transmission: Carried by insects like ticks, mosquitoes, or flies.

Environmental Transmission: Through contaminated soil, water, or air.

These diseases can lead to significant economic losses in agriculture, reduce productivity, and in some cases, pose serious public health risks due to zoonotic transmission (diseases that can be transmitted from animals to humans).

Prevention and Control

Vaccination: Effective for preventing many viral and bacterial diseases.

Quarantine: Isolating infected animals to prevent the spread of disease.

Good Hygiene Practices: Regular cleaning and disinfection of animal housing, equipment, and environment.

Vector Control: Managing and reducing the population of disease-carrying insects.

Regular Monitoring and Surveillance: Early detection and response to outbreaks can prevent widespread infection.

Understanding and managing animal infectious diseases is crucial for animal health, public health, and maintaining food security.

 

[post_grid id="9882"]